Your browser doesn't support javascript.
loading
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden.
Marinelli, D; Mazzotta, M; Scalera, S; Terrenato, I; Sperati, F; D'Ambrosio, L; Pallocca, M; Corleone, G; Krasniqi, E; Pizzuti, L; Barba, M; Carpano, S; Vici, P; Filetti, M; Giusti, R; Vecchione, A; Occhipinti, M; Gelibter, A; Botticelli, A; De Nicola, F; Ciuffreda, L; Goeman, F; Gallo, E; Visca, P; Pescarmona, E; Fanciulli, M; De Maria, R; Marchetti, P; Ciliberto, G; Maugeri-Saccà, M.
Afiliación
  • Marinelli D; Department of Clinical and Molecular Medicine, Oncology Unit, Sant'Andrea Hospital, Sapienza University, Rome, Italy.
  • Mazzotta M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Scalera S; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Terrenato I; Biostatistics-Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Sperati F; Biostatistics Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
  • D'Ambrosio L; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Pallocca M; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Corleone G; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Krasniqi E; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Pizzuti L; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Barba M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Carpano S; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Vici P; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Filetti M; Department of Clinical and Molecular Medicine, Oncology Unit, Sant'Andrea Hospital, Sapienza University, Rome, Italy.
  • Giusti R; Medical Oncology Unit, Sant'Andrea Hospital, Rome, Italy.
  • Vecchione A; Department of Clinical and Molecular Medicine, Pathology Unit, Sant'Andrea Hospital, Sapienza University, Rome, Italy.
  • Occhipinti M; Medical Oncology Unit B, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Gelibter A; Medical Oncology Unit B, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Botticelli A; Medical Oncology Unit B, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • De Nicola F; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Ciuffreda L; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Goeman F; Oncogenomic and Epigenetic Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Gallo E; Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Visca P; Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Pescarmona E; Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Fanciulli M; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • De Maria R; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Institute of General Pathology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Marchetti P; Department of Clinical and Molecular Medicine, Oncology Unit, Sant'Andrea Hospital, Sapienza University, Rome, Italy; Medical Oncology Unit B, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Ciliberto G; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Maugeri-Saccà M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: marcello.maugerisacca@ifo.gov.it.
Ann Oncol ; 31(12): 1746-1754, 2020 12.
Article en En | MEDLINE | ID: mdl-32866624
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Italia